| abstract |
A solid pharmaceutical dosage form for the delivery of nicotine into the oral cavity comprising a core encapsulated by at least one film coating, wherein the core comprises nicotine and wherein the film coating comprises at least one film-forming polymer and at least one component for the reduction of one or more organoleptically disturbing sensations, and wherein the at least one film coating is devoid of nicotine and devoid of buffer; wherein said dosage form is a lozenge, a sublingual tablet, a buccal tablet, or an orally disintegrating tablet. |